DDD Partners’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.1M Sell
615,091
-2,993
-0.5% -$69.2K 0.94% 44
2026
Q1
$14.8M Sell
618,084
-308,934
-33% -$7.55M 1.02% 36
2025
Q4
$21M Sell
927,018
-826,351
-47% -$18M 1.34% 19
2025
Q3
$35.3M Buy
1,753,369
+108,941
+7% +$1.83M 2.24% 5
2025
Q2
$23.5M Buy
1,644,428
+151,436
+10% +$1.77M 2.52% 10
2025
Q1
$15.7M Buy
1,492,992
+999,716
+203% +$11.3M 1.9% 25
2024
Q4
$5.97M Buy
+493,276
New +$6.45M 0.73% 37

Other funds holding ELAN

DDD Partners's ELAN Position: Q2 2026 in Review

DDD Partners reduced its Elanco Animal Health (ELAN) stake by 0.48% in Q2 2026, selling an estimated $69.2K and leaving 615,091 shares worth $15.1M. The position accounts for 0.94% of the portfolio, ranked #44.

DDD Partners first reported a position in ELAN in Q4 2024 and has held it in 7 quarters since. The position peaked at $35.3M in Q3 2025. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • DDD Partners held 615,091 shares of Elanco Animal Health worth $15.1M as of Q2 2026.
  • DDD Partners sold 2,993 Elanco Animal Health shares in Q2 2026, an estimated $69.2K.
  • Elanco Animal Health made up 0.94% of DDD Partners's portfolio in Q2 2026, its #44 holding.
  • DDD Partners first reported a position in Elanco Animal Health in Q4 2024 and has held it in 7 quarters since.
  • DDD Partners's Elanco Animal Health position peaked at $35.3M in Q3 2025.
  • 523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on DDD Partners's 13F filing for Q2 2026, filed 5 Aug 2026.